Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
XFOR
X4 Pharmaceuticals, Inc
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$2.90
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$287.53M
Country
USA
RECENT INSIDER TRADES
2026-10-05
· KIRSKE DAVID
(Chief Financial Officer)
· SELL
2026-08-13
· Volpone John
(President)
· SELL
2026-08-13
· Craig Adam R
(Executive Chairman)
· SELL
2026-07-01
· KIRSKE DAVID
(Chief Financial Officer)
· SELL
2026-05-13
· KIRSKE DAVID
(Chief Financial Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
96
Shares held
113,549,614
Value
$482.48M
Percent of shares outstanding
114.53%
As of quarter end
2026-06-30
RECENT NEWS
X4 Pharmaceuticals to host virtual investor day October 29
X4 Pharmaceuticals secures up to $150M debt facility
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
XFOR: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals, Inc · 8-K
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS